6.
Grant C, Rhee D, Tracy E, Aldrink J, Baertschiger R, Lautz T
. Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee. J Pediatr Surg. 2021; 57(3):430-442.
DOI: 10.1016/j.jpedsurg.2021.08.008.
View
7.
Khanna L, Prasad S, Yedururi S, Parameswaran A, Marcal L, Sandrasegaran K
. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings. Radiographics. 2021; 41(3):876-894.
DOI: 10.1148/rg.2021200171.
View
8.
Rossini L, Durante C, Bresolin S, Opocher E, Marzollo A, Biffi A
. Diagnostic Strategies and Algorithms for Investigating Cancer Predisposition Syndromes in Children Presenting with Malignancy. Cancers (Basel). 2022; 14(15).
PMC: 9367486.
DOI: 10.3390/cancers14153741.
View
9.
Radtke H, Berger A, Skelton T, Weisman A
. Neurofibromatosis Type 1 (NF1): Addressing the Transition from Pediatric to Adult Care. Pediatric Health Med Ther. 2023; 14:19-32.
PMC: 9925753.
DOI: 10.2147/PHMT.S362679.
View
10.
Ward Z, Yeh J, Bhakta N, Frazier A, Atun R
. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019; 20(4):483-493.
DOI: 10.1016/S1470-2045(18)30909-4.
View
11.
Woodward E, Meyer S
. Fanconi Anaemia, Childhood Cancer and the Genes. Genes (Basel). 2021; 12(10).
PMC: 8535386.
DOI: 10.3390/genes12101520.
View
12.
Duzkale N, Kandemir O
. The Relationship of Mutation Carriage of and Family History in Triple-Negative Breast Cancer: Experience from a Diagnostic Center in Turkey. Eur J Breast Health. 2021; 17(2):137-144.
PMC: 8025727.
DOI: 10.4274/ejbh.galenos.2020.5909.
View
13.
Hata A, Kashima R
. Dysregulation of microRNA biogenesis machinery in cancer. Crit Rev Biochem Mol Biol. 2015; 51(3):121-34.
PMC: 5226641.
DOI: 10.3109/10409238.2015.1117054.
View
14.
Rosenbaum T, Wimmer K
. Neurofibromatosis type 1 (NF1) and associated tumors. Klin Padiatr. 2014; 226(6-7):309-15.
DOI: 10.1055/s-0034-1382021.
View
15.
Kratz C, Jongmans M, Cave H, Wimmer K, Behjati S, Guerrini-Rousseau L
. Predisposition to cancer in children and adolescents. Lancet Child Adolesc Health. 2021; 5(2):142-154.
DOI: 10.1016/S2352-4642(20)30275-3.
View
16.
Newman S, Nakitandwe J, Kesserwan C, Azzato E, Wheeler D, Rusch M
. Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing. Cancer Discov. 2021; 11(12):3008-3027.
PMC: 8783930.
DOI: 10.1158/2159-8290.CD-20-1631.
View
17.
Siegel R, Miller K, Fuchs H, Jemal A
. Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33.
DOI: 10.3322/caac.21708.
View
18.
Meyer S, Tischkowitz M, Chandler K, Gillespie A, Birch J, Evans D
. Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling. J Med Genet. 2013; 51(2):71-5.
DOI: 10.1136/jmedgenet-2013-101642.
View
19.
Hill D, Ivanovich J, Priest J, Gurnett C, Dehner L, Desruisseau D
. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009; 325(5943):965.
PMC: 3098036.
DOI: 10.1126/science.1174334.
View
20.
Steliarova-Foucher E, Colombet M, Ries L, Moreno F, Dolya A, Bray F
. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017; 18(6):719-731.
PMC: 5461370.
DOI: 10.1016/S1470-2045(17)30186-9.
View